May indication expansions boost Cialis?

Published: 2012-06-14 06:59:00

Updated: 2012-06-14 06:59:00

The Korea Food and Drug Administration has recently approved Eli Lilly's Cialis to treat men with symptoms of benign prostatic hyperplasia (BPH) alone or with both BPH symptoms and erectile dysfunction.

Market observers say that the regulator's decision may make Cialis the first drug to offer...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK